Pointstate Capital LP Stake in Xylem (XYL) Has Decreased as Valuation Rose; Kellogg Co (K) Holder Comerica Bank Lowered Holding by $447,238 as Stock Declined

January 13, 2018 - By Adrian Erickson

Comerica Bank decreased its stake in Kellogg Co (K) by 6.04% based on its latest 2017Q3 regulatory filing with the SEC. Comerica Bank sold 7,711 shares as the company’s stock declined 2.57% while stock markets rallied. The institutional investor held 119,979 shares of the packaged foods company at the end of 2017Q3, valued at $7.06M, down from 127,690 at the end of the previous reported quarter. Comerica Bank who had been investing in Kellogg Co for a number of months, seems to be less bullish one the $22.35B market cap company. The stock decreased 1.96% or $1.29 during the last trading session, reaching $64.69. About 4.94M shares traded or 43.08% up from the average. Kellogg Company (NYSE:K) has declined 5.60% since January 13, 2017 and is downtrending. It has underperformed by 22.30% the S&P500.

Pointstate Capital Lp decreased its stake in Xylem Inc (XYL) by 56.89% based on its latest 2017Q3 regulatory filing with the SEC. Pointstate Capital Lp sold 350,300 shares as the company’s stock rose 8.81% with the market. The hedge fund held 265,400 shares of the fluid controls company at the end of 2017Q3, valued at $16.62 million, down from 615,700 at the end of the previous reported quarter. Pointstate Capital Lp who had been investing in Xylem Inc for a number of months, seems to be less bullish one the $12.66B market cap company. The stock increased 0.70% or $0.49 during the last trading session, reaching $70.46. About 847,704 shares traded or 4.81% up from the average. Xylem Inc. (NYSE:XYL) has risen 20.76% since January 13, 2017 and is uptrending. It has outperformed by 4.06% the S&P500.

Analysts await Kellogg Company (NYSE:K) to report earnings on February, 8 before the open. They expect $0.96 EPS, up 4.35% or $0.04 from last year’s $0.92 per share. K’s profit will be $331.66M for 16.85 P/E if the $0.96 EPS becomes a reality. After $1.05 actual EPS reported by Kellogg Company for the previous quarter, Wall Street now forecasts -8.57% negative EPS growth.

Investors sentiment increased to 0.86 in Q3 2017. Its up 0.03, from 0.83 in 2017Q2. It is positive, as 60 investors sold K shares while 205 reduced holdings. 47 funds opened positions while 180 raised stakes. 307.00 million shares or 3.54% more from 296.50 million shares in 2017Q2 were reported. The Ontario – Canada-based Td Asset Management Inc has invested 0.1% in Kellogg Company (NYSE:K). Employees Retirement Systems Of Texas, a Texas-based fund reported 15,000 shares. Toronto Dominion Bancshares has 0.03% invested in Kellogg Company (NYSE:K) for 142,516 shares. Geode Cap Mngmt Limited Liability Corporation holds 0.06% or 2.53 million shares in its portfolio. Fort Washington Inv Advsrs Oh invested in 28,927 shares or 0.03% of the stock. Willis Counsel has 117,325 shares for 0.53% of their portfolio. Clifford Swan Inv Counsel Limited Co has 18,586 shares for 0.07% of their portfolio. Lvm Management Mi holds 0.39% of its portfolio in Kellogg Company (NYSE:K) for 25,862 shares. National Bank Of Ny Mellon Corporation invested in 0.07% or 4.19M shares. 109,808 were reported by Sei. Nomura holds 0% or 30,748 shares in its portfolio. Cornerstone Capital Limited Liability Corporation stated it has 42,658 shares. Moreover, Stifel Finance has 0.01% invested in Kellogg Company (NYSE:K) for 63,736 shares. The Germany-based Dekabank Deutsche Girozentrale has invested 0.39% in Kellogg Company (NYSE:K). First Personal Financial has 0% invested in Kellogg Company (NYSE:K).

Comerica Bank, which manages about $13.82 billion US Long portfolio, upped its stake in Cantel Medical Corporation (NYSE:CMN) by 6,163 shares to 44,236 shares, valued at $4.20M in 2017Q3, according to the filing. It also increased its holding in Pool Corp Com (NASDAQ:POOL) by 8,756 shares in the quarter, for a total of 42,034 shares, and has risen its stake in Calavo Growers Inc (NASDAQ:CVGW).

Since December 13, 2017, it had 0 insider purchases, and 1 insider sale for $165.17 billion activity.

Among 23 analysts covering Kellogg Company (NYSE:K), 8 have Buy rating, 1 Sell and 14 Hold. Therefore 35% are positive. Kellogg Company had 61 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, October 25 by RBC Capital Markets. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, May 5. The company was maintained on Wednesday, October 18 by RBC Capital Markets. Citigroup maintained the stock with “Buy” rating in Thursday, April 14 report. S&P Research maintained the shares of K in report on Wednesday, August 5 with “Hold” rating. The stock has “Hold” rating by Deutsche Bank on Wednesday, February 15. Argus Research upgraded the stock to “Buy” rating in Wednesday, November 22 report. The stock has “Hold” rating by Susquehanna on Thursday, August 3. The firm has “Equal-Weight” rating given on Friday, October 13 by Morgan Stanley. The stock has “Buy” rating by Buckingham Research on Monday, October 19.

Analysts await Xylem Inc. (NYSE:XYL) to report earnings on February, 1. They expect $0.76 EPS, up 15.15% or $0.10 from last year’s $0.66 per share. XYL’s profit will be $136.50M for 23.18 P/E if the $0.76 EPS becomes a reality. After $0.65 actual EPS reported by Xylem Inc. for the previous quarter, Wall Street now forecasts 16.92% EPS growth.

Among 19 analysts covering Xylem (NYSE:XYL), 12 have Buy rating, 0 Sell and 7 Hold. Therefore 63% are positive. Xylem had 65 analyst reports since August 3, 2015 according to SRatingsIntel. Cowen & Co maintained Xylem Inc. (NYSE:XYL) on Thursday, September 3 with “Outperform” rating. As per Wednesday, July 12, the company rating was maintained by Oppenheimer. Stifel Nicolaus maintained Xylem Inc. (NYSE:XYL) rating on Wednesday, November 2. Stifel Nicolaus has “Hold” rating and $48 target. Stifel Nicolaus upgraded Xylem Inc. (NYSE:XYL) rating on Thursday, September 3. Stifel Nicolaus has “Buy” rating and $37.0 target. The firm earned “Neutral” rating on Monday, November 28 by Boenning & Scattergood. The stock of Xylem Inc. (NYSE:XYL) has “Buy” rating given on Monday, July 10 by RBC Capital Markets. The firm earned “Buy” rating on Wednesday, January 3 by RBC Capital Markets. The rating was maintained by Cowen & Co on Wednesday, September 20 with “Buy”. The rating was maintained by Oppenheimer on Tuesday, June 20 with “Buy”. Robert W. Baird maintained it with “Hold” rating and $71.0 target in Tuesday, October 31 report.

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.19, from 1.2 in 2017Q2. It dived, as 25 investors sold XYL shares while 179 reduced holdings. 55 funds opened positions while 151 raised stakes. 146.94 million shares or 0.93% less from 148.32 million shares in 2017Q2 were reported. Cibc Ww Markets reported 26,166 shares stake. Essex Inv Management Limited Co holds 0.17% or 20,349 shares. Sandy Spring Bank accumulated 168 shares. Oppenheimer accumulated 0.24% or 144,396 shares. Sei Invests holds 49,085 shares. Bluecrest Mgmt Limited accumulated 4,126 shares. Balyasny Asset Management Llc stated it has 0% of its portfolio in Xylem Inc. (NYSE:XYL). Caprock Group accumulated 0.13% or 9,822 shares. Moreover, Hartford Inv has 0.05% invested in Xylem Inc. (NYSE:XYL) for 38,848 shares. Carret Asset Mgmt Limited Liability Company, New York-based fund reported 20,146 shares. Bessemer Grp Incorporated has 7,035 shares. New York State Common Retirement Fund stated it has 574,517 shares or 0.05% of all its holdings. Fjarde Ap reported 45,181 shares. Hm Payson & owns 23,713 shares for 0.06% of their portfolio. Cleararc Cap Incorporated has 0.04% invested in Xylem Inc. (NYSE:XYL) for 4,618 shares.

Pointstate Capital Lp, which manages about $10.76B and $11.77B US Long portfolio, upped its stake in Zayo Group Hldgs Inc (NYSE:ZAYO) by 342,015 shares to 527,915 shares, valued at $18.17 million in 2017Q3, according to the filing. It also increased its holding in Spdr S&P 500 Etf Tr (Call) (SPY) by 1.88 million shares in the quarter, for a total of 2.76 million shares, and has risen its stake in Prothena Corp Plc (NASDAQ:PRTA).

Since August 9, 2017, it had 0 insider purchases, and 6 insider sales for $5.14 million activity. Shares for $544,578 were sold by Napolitano Kenneth. Another trade for 2,260 shares valued at $153,108 was sold by Brannemo Tomas.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>